Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults

• मुख्य लेखकों: Javier Díez-Domingo (लेखक), Juan Carlos Tinoco (लेखक), Airi Poder (लेखक), Ener Cagri Dinleyici (लेखक), Haylene Nell (लेखक), Ignacio Salamanca de la Cueva (लेखक), Tolga Ince (लेखक), Edson Duarte Moreira (लेखक), Khatija Ahmed (लेखक), Kleber Luz (लेखक), Yulia Kovshirina (लेखक), Carlos Eduardo Medina Pech (लेखक), Tauseefullah Akhund (लेखक), Valerio Romolini (लेखक), Marco Costantini (लेखक), Thembile Mzolo (लेखक), Barry Kunnel (लेखक), Isabelle Lechevin (लेखक), Marianna Aggravi (लेखक), Paola Tiberi (लेखक), K Narendran (लेखक), Juan-Antonio (लेखक), Venere Basile (लेखक), Elena Fragapane (लेखक), Maria Lattanzi (लेखक), Michele Pellegrini (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Taylor & Francis Group, 2022-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

A fully liquid MenACWY-CRM vaccine presentation has been developed, modifying the meningococcal serogroup A (MenA) component from lyophilized to liquid. The safety and immunogenicity of the liquid presentation at the end of the intended shelf-life (aged for 24 or 30 months) were compared to the lice...